Loading...
NPI 1417627886 · Tulsa, OK · Community/Retail Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Tru Script Pharmacy LLC is a community/retail pharmacy provider located in Tulsa, Oklahoma. This profile covers 1 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Tru Script Pharmacy LLC |
| Address | 6048 S Sheridan Rd Ste C |
| City | Tulsa |
| State | OK |
| ZIP | 74145 |
| Taxonomy | Community/Retail Pharmacy |
| NPI Enumerated | September 17, 2021 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $26M |
| Medicaid | $150 |
TRU SCRIPT PHARMACY LLC appears to operate primarily as a point-of-care or retail COVID-19 test dispenser: its entire reported Medicare revenue ($26M) is driven 100.0% by a single HCPCS code, K1034, which corresponds to provision of nonprescription self-administered COVID-19 tests. This code mix indicates the pharmacy’s Medicare-facing service line is focused on distribution of FDA-approved/authorized COVID-19 self-test kits rather than traditional dispensing or clinical services billed to Medicare.
Revenue concentration on Medicare is extremely high: the precomputed top-3 codes share shows that the top 3 Medicare codes account for 100.0% of the provider’s Medicare revenue, meaning Medicare receipts are effectively mono-coded and wholly attributable to COVID-19 test provisioning under K1034. This represents a concentrated payer-code exposure for the Medicare side of the business.
By scale, the provider’s Medicaid revenue ($147) is negligible compared with Medicare revenue ($26M), signaling an effectively Medicare-dominant billing footprint in the available data. Analysts should treat TRU SCRIPT PHARMACY LLC as functionally single-payer in practice, with meaningful activity concentrated in Medicare-sourced COVID-19 test reimbursements.
On competitive standing for the Medicare code K1034, TRU SCRIPT PHARMACY LLC ranks #12 of 30,143 providers nationally and is listed at the 100th percentile; the platform labels this an extreme outlier and TRU SCRIPT’s volume for this code is far above typical national activity. This ranking indicates the pharmacy is a national-scale high-volume distributor of this specific COVID-19 test product relative to peers.
The nature of the billed code (K1034 — provision of nonprescription self-administered COVID-19 tests) and the very large counts reported (2.2M claims) suggest the entity functions operationally as a high-throughput retail or fulfillment channel for over-the-counter tests rather than a conventional pharmacy-only dispensing model. The average paid per claim ($12) combined with large claim volume yields the bulk of the reported Medicare revenue.
Tenure is short but established: the NPI was enumerated on 2021-09-17 (~5 years ago), consistent with an entity that likely scaled operations during the COVID-19 pandemic period when self-test distribution was in high demand. This timing aligns with the billing profile heavily weighted toward COVID-19 test provision.
Given the mono-code Medicare revenue profile and extremely high national rank for K1034, competitive risk factors are concentrated—changes in Medicare coverage, reimbursement policy for K1034, or supply constraints for self-test kits could materially affect the provider’s Medicare revenue. Conversely, the current profile shows a successful niche operation in pandemic-related test distribution at scale.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 2,208,780 | $10 | $26.5M |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 1 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
1 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| K1034 | 1 | 330 | 260 | $10 | $123.3K |
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 4,900 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Oklahoma providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Oklahoma median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 1 | 10 | 740 | $1 | $210 |
Other providers in the same ZIP code as Tru Script Pharmacy LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.